CompanyPrivateWilmington, DE

Synnovation Therapeutics, INC

SEC EDGAR ClinicalTrials.gov

424B4Sep 28Latest SEC filing

Form DDec 21$15M sold

August 2026

Synnovation registers Phase 1 trial of SNV1521 with Revolution Medicines' daraxonrasib

Aug 10Trial updatedaraxonrasib Revolution Medicines, Inc.